This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignees: Korea University Industrial Academic Collaboration Foundation, Korea University Industry and Academy Cooperation Foundation, Other. Active years: 2004-2011.
Company Filing History:
3 out of 86 
1 out of 22 
1 out of 834,350 Years Active: 2004-2011
Title: Sun Wook Hwang: Innovator in Pain Management
Introduction
Sun Wook Hwang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pain management through his innovative research and patents. With a total of five patents to his name, Hwang is recognized for his work on TRPA1 activation inhibitors.
Latest Patents
Hwang's latest patents include a compound for inhibiting TRPA1 function and a method for activating the transient receptor potential cation channel, subfamily A, member 1 using acetaldehyde. The first patent describes a TRPA1 activity inhibitor that contains isopentenyl pyrophosphate. This invention aims to regulate pain caused by TRPA1, making it a potential candidate for developing effective pain inhibitors with fewer side effects. The second patent outlines a method for selecting a candidate for TRPA1 activation blockers from neurons activated by acetaldehyde. This method facilitates the isolation of sensory neurons expressing TRPA1, which can be beneficial for studying TRPA1 mechanisms and developing TRPA1-based analgesics.
Career Highlights
Hwang has worked with the Korea University Industry and Academic Collaboration Foundation, where he has contributed to various research initiatives. His work has focused on understanding pain mechanisms and developing innovative solutions to manage pain effectively.
Collaborations
Some of Hwang's notable coworkers include Sang-Soo Bang and Uhtaek Oh. Their collaborative efforts have further advanced the research in the field of pain management.
Conclusion
Sun Wook Hwang is a key figure in the innovation of pain management solutions. His patents and research contributions continue to pave the way for advancements in this critical area of healthcare.